Prospective precision oncology registries PRAEGNANT and CATCH improve outcome of patients with metastatic breast cancer in Germany

Autor: Schneeweiss, A, Hlevnjak, M, Schulze, M, Hartkopf, A, Mueller, V, Fehm, T, Ettl, J, Wimberger, P, Fremd, C, Michel, L, Gieldon, L, Smetanay, K, Sinn, HP, Jäger, D, Zapatka, M, Brucker, S, Thewes, V, Belleville, E, Lichter, P, Fasching, PA

Publikováno v: 20. Deutscher Kongress für Versorgungsforschung (DKVF); 20211006-20211008; sine loco [digital]; DOC21dkvf229 /20210927/

Purpose: PRAEGNANT (PRospective AcadEmic translational research network for the optimization of the oncoloGical health care quality iN the AdvaNced therapeutic seTting) and CATCH (Comprehensive Assessment of clinical feaTures and biomarkers to identi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8f9e74c0c2d2589f2769b7f029a20de

Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine.

Autor: Horak P; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; Center for Personalized Medicine (ZPM), Heidelberg, Germany., Leichsenring J; Institut für Pathologie, Zytologie und molekulare Diagnostik, Regiomed Klinikum Coburg, Coburg, Germany.; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Goldschmid H; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Kreutzfeldt S; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany., Kazdal D; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; German Center for Lung Research (DZL), Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg, Germany., Teleanu V; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Endris V; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Gieldon L; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany., Allgäuer M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Volckmar AL; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Dikow N; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany., Renner M; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany., Kirchner M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Penzel R; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Ploeger C; Center for Personalized Medicine (ZPM), Heidelberg, Germany.; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Brandt R; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Seker-Cin H; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Budczies J; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; German Center for Lung Research (DZL), Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg, Germany., Heilig CE; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany., Neumann O; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Schaaf CP; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany., Schirmacher P; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; Center for Personalized Medicine (ZPM), Heidelberg, Germany.; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Fröhling S; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; Center for Personalized Medicine (ZPM), Heidelberg, Germany., Stenzinger A; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; Center for Personalized Medicine (ZPM), Heidelberg, Germany.; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; German Center for Lung Research (DZL), Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg, Germany.

Publikováno v: Genes, chromosomes & cancer [Genes Chromosomes Cancer] 2022 Jun; Vol. 61 (6), pp. 303-313. Date of Electronic Publication: 2021 Aug 09.

Publisher Correction: Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemia.

Autor: Horak P; German Cancer Consortium (DKTK), Heidelberg, Germany. peter.horak@nct-heidelberg.de.; Division of Translational Medical Oncology, DKFZ and NCT Heidelberg, Heidelberg, Germany. peter.horak@nct-heidelberg.de., Uhrig S; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Witzel M; Department of Pediatrics, Dr. von Hauner Children's Hospital, Ludwig Maximilians University, Munich, Germany., Gil-Farina I; Division of Translational Oncology, DKFZ and NCT Heidelberg, Heidelberg, Germany., Hutter B; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Rath T; Division of Translational Oncology, DKFZ and NCT Heidelberg, Heidelberg, Germany.; GeneWerk GmbH, Heidelberg, Germany., Gieldon L; Institute for Clinical Genetics, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; German Cancer Consortium (DKTK) Dresden and DKFZ, Heidelberg, Germany.; NCT Dresden, Dresden, Germany., Balasubramanian GP; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.; Division of Pediatric Neurooncology, DKFZ, Heidelberg, Germany., Pastor X; Division of Theoretical Bioinformatics, DKFZ, Heidelberg, Germany.; Heidelberg Center for Personalized Oncology (DKFZ-HIPO), Heidelberg, Germany., Heilig CE; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Translational Medical Oncology, DKFZ and NCT Heidelberg, Heidelberg, Germany., Richter D; Department of Translational Medical Oncology, NCT Dresden, Dresden, Germany.; University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Schröck E; Institute for Clinical Genetics, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; German Cancer Consortium (DKTK) Dresden and DKFZ, Heidelberg, Germany.; NCT Dresden, Dresden, Germany., Ball CR; Department of Translational Medical Oncology, NCT Dresden, Dresden, Germany.; University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Brors B; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Braun CJ; Department of Pediatrics, Dr. von Hauner Children's Hospital, Ludwig Maximilians University, Munich, Germany., Albert MH; Department of Pediatrics, Dr. von Hauner Children's Hospital, Ludwig Maximilians University, Munich, Germany., Scholl C; Division of Applied Functional Genomics, DKFZ, Heidelberg, Germany., von Kalle C; Division of Translational Oncology, DKFZ and NCT Heidelberg, Heidelberg, Germany.; GeneWerk GmbH, Heidelberg, Germany., Schmidt M; Division of Translational Oncology, DKFZ and NCT Heidelberg, Heidelberg, Germany.; GeneWerk GmbH, Heidelberg, Germany., Fröhling S; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Translational Medical Oncology, DKFZ and NCT Heidelberg, Heidelberg, Germany., Klein C; Department of Pediatrics, Dr. von Hauner Children's Hospital, Ludwig Maximilians University, Munich, Germany., Glimm H; Department of Translational Medical Oncology, NCT Dresden, Dresden, Germany. hanno.glimm@nct-dresden.de.; University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. hanno.glimm@nct-dresden.de.

Publikováno v: Leukemia [Leukemia] 2021 Dec; Vol. 35 (12), pp. 3633.

Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers.

Autor: Horak P; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Heining C; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; DKTK, Dresden, Germany., Kreutzfeldt S; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Hutter B; Computational Oncology Group, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Division of Applied Bioinformatics, DKFZ, Heidelberg., Mock A; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany., Hüllein J; Computational Oncology Group, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany., Fröhlich M; Computational Oncology Group, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Division of Applied Bioinformatics, DKFZ, Heidelberg., Uhrig S; Computational Oncology Group, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Division of Applied Bioinformatics, DKFZ, Heidelberg., Jahn A; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; DKTK, Dresden, Germany.; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Rump A; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; DKTK, Dresden, Germany.; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Gieldon L; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany., Möhrmann L; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; DKTK, Dresden, Germany., Hanf D; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; DKTK, Dresden, Germany., Teleanu V; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Heilig CE; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Lipka DB; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Allgäuer M; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Ruhnke L; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; DKTK, Dresden, Germany., Laßmann A; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany., Endris V; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Neumann O; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Penzel R; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Beck K; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Richter D; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; DKTK, Dresden, Germany., Winter U; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Wolf S; German Cancer Consortium (DKTK), Heidelberg, Germany.; High-Throughput Sequencing Unit, Genomics and Proteomics Core Facility, DKFZ, Heidelberg, Germany., Pfütze K; German Cancer Consortium (DKTK), Heidelberg, Germany.; Sample Processing Laboratory, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany., Geörg C; German Cancer Consortium (DKTK), Heidelberg, Germany.; Sample Processing Laboratory, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany., Meißburger B; German Cancer Consortium (DKTK), Heidelberg, Germany.; Sample Processing Laboratory, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany., Buchhalter I; Omics IT and Data Management Core Facility, DKFZ, Heidelberg, Germany., Augustin M; Department of Hematology and Oncology, Klinikum Nuremberg, Paracelsus Medical University, Nuremberg, Germany., Aulitzky WE; Department of Hematology, Oncology and Palliative Medicine, Robert Bosch Hospital, Stuttgart, Germany., Hohenberger P; Sarcoma Unit, Interdisciplinary Tumor Center Mannheim, Mannheim University Medical Center, Heidelberg University, Mannheim, Germany.; Department of Surgery, Mannheim University Medical Center, Heidelberg University, Mannheim, Germany., Kroiss M; Department of Medicine I, Würzburg University Hospital, Würzburg, Germany.; Comprehensive Cancer Mainfranken, University of Würzburg, Würzburg, Germany.; Department of Medicine IV, University Hospital, Ludwig Maximilians University Munich, Munich, Germany., Schirmacher P; German Cancer Consortium (DKTK), Heidelberg, Germany.; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Schlenk RF; German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; NCT Trial Center, NCT Heidelberg and DKFZ, Heidelberg, Germany., Keilholz U; Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.; DKTK, Berlin, Germany., Klauschen F; DKTK, Berlin, Germany.; Institute of Pathology, Charité - Universitätsmedizin Berlin, and Berlin Institute of Health, Berlin, Germany., Folprecht G; DKTK, Dresden, Germany.; Department of Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Bauer S; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; DKTK, Essen, Germany., Siveke JT; DKTK, Essen, Germany.; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, DKTK, Essen, and DKFZ, Heidelberg, Germany., Brandts CH; University Cancer Center (UCT) Frankfurt, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.; Department of Medicine, Hematology/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.; Frankfurt Cancer Institute, Frankfurt, Germany.; DKTK, Frankfurt, Germany., Kindler T; UCT Mainz, Johannes Gutenberg University Mainz, Mainz, Germany.; Department of Hematology, Medical Oncology and Pneumology, University Medical Center, Mainz, Germany.; DKTK, Mainz, Germany., Boerries M; Comprehensive Cancer Center Freiburg, University of Freiburg Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Institute of Medical Bioinformatics and Systems Medicine, University of Freiburg Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; DKTK, Freiburg, Germany., Illert AL; Comprehensive Cancer Center Freiburg, University of Freiburg Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; DKTK, Freiburg, Germany.; Department of Internal Medicine I, University of Freiburg Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., von Bubnoff N; Department of Internal Medicine I, University of Freiburg Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Lübeck, Germany., Jost PJ; Department of Hematology and Oncology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.; Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria.; DKTK, Munich, Germany., Spiekermann K; DKTK, Munich, Germany.; Department of Medicine III, University Hospital, Ludwig Maximilians University Munich, Munich, Germany., Bitzer M; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.; DKTK, Tübingen, Germany., Schulze-Osthoff K; DKTK, Tübingen, Germany.; Department of Molecular Medicine, Interfaculty Institute for Biochemistry, University of Tübingen, Tübingen, Germany., von Kalle C; Clinical Study Center, Charité - Universitätsmedizin Berlin, and Berlin Institute of Health, Berlin, Germany., Klink B; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; DKTK, Dresden, Germany.; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; National Center of Genetics, Laboratoire National de Santé, Dudelange, Luxembourg.; Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg., Brors B; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Applied Bioinformatics, DKFZ, Heidelberg., Stenzinger A; German Cancer Consortium (DKTK), Heidelberg, Germany.; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Schröck E; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; DKTK, Dresden, Germany.; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Hübschmann D; German Cancer Consortium (DKTK), Heidelberg, Germany.; Computational Oncology Group, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine, Heidelberg, Germany., Weichert W; DKTK, Munich, Germany.; Institute of Pathology, Technical University Munich, Munich, Germany., Glimm H; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany. stefan.froehling@nct-heidelberg.de hanno.glimm@nct-dresden.de.; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; DKTK, Dresden, Germany., Fröhling S; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany. stefan.froehling@nct-heidelberg.de hanno.glimm@nct-dresden.de.; German Cancer Consortium (DKTK), Heidelberg, Germany.

Publikováno v: Cancer discovery [Cancer Discov] 2021 Nov; Vol. 11 (11), pp. 2780-2795. Date of Electronic Publication: 2021 Jun 10.

Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma.

Autor: Richter S; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. Susan.Richter2@uniklinikum-dresden.de., Gieldon L; Institute for Clinical Genetics, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Pang Y; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA., Peitzsch M; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Huynh T; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA., Leton R; Hereditary Endocrine Cancer Group, CNIO, Madrid, Spain and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain., Viana B; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA., Ercolino T; Azienda Ospedaliero-Universitaria Careggi, Endocrinology Unit, Florence, Italy., Mangelis A; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Rapizzi E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Menschikowski M; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Aust D; Institute of Pathology, Tumor and Normal Tissue Bank of the UCC/NCT Dresden, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Kroiss M; Department of Internal Medicine, Division of Endocrinology, University Hospital, University of Würzburg, Würzburg, Germany., Beuschlein F; Medizinische Klinik and Poliklinik IV, Ludwig-Maximilians-Universität München, Munich, Germany.; Department for Endocrinology, Diabetology and Clinical Nutrition, UniversitätsSpital Zürich, Zurich, Switzerland., Gudziol V; Departments of Otorhinolaryngology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Timmers HJ; Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands., Lenders J; Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.; Department of Medicine III, University Hospital Dresden, Dresden, Germany., Mannelli M; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Cascon A; Hereditary Endocrine Cancer Group, CNIO, Madrid, Spain and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain., Pacak K; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA., Robledo M; Hereditary Endocrine Cancer Group, CNIO, Madrid, Spain and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain., Eisenhofer G; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Department of Medicine III, University Hospital Dresden, Dresden, Germany., Klink B; Institute for Clinical Genetics, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Publikováno v: Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2019 Mar; Vol. 21 (3), pp. 705-717. Date of Electronic Publication: 2018 Jul 27.